A survey on clinical effectiveness of orlistat compared to sibutramine, lorcaserin, metformin and placebo on weight loss in obese people: a network meta-analysis

Background: Trying to find a drug with more clinical efficacy in treating obesity is one of the priorities. The aim of this study was to evaluate the efficacy of orlistat, sibutramine, lorcaserin and metformin on weight loss in obese people. Methods: The databases of PubMed, Scopus, Google Scholar a...

Full description

Bibliographic Details
Main Authors: Somaye Fatahi, Hamed Kord Varkaneh, Mehran Pezeshki, Amirhosein Ghahremanian, Sakineh Shab-Bidar
Format: Article
Language:fas
Published: Tehran University of Medical Sciences 2018-09-01
Series:Tehran University Medical Journal
Subjects:
Online Access:http://tumj.tums.ac.ir/browse.php?a_code=A-10-3666-83&slc_lang=en&sid=1
_version_ 1811338686953947136
author Somaye Fatahi
Hamed Kord Varkaneh
Mehran Pezeshki
Amirhosein Ghahremanian
Sakineh Shab-Bidar
author_facet Somaye Fatahi
Hamed Kord Varkaneh
Mehran Pezeshki
Amirhosein Ghahremanian
Sakineh Shab-Bidar
author_sort Somaye Fatahi
collection DOAJ
description Background: Trying to find a drug with more clinical efficacy in treating obesity is one of the priorities. The aim of this study was to evaluate the efficacy of orlistat, sibutramine, lorcaserin and metformin on weight loss in obese people. Methods: The databases of PubMed, Scopus, Google Scholar and Cochran Library were searched up to November 2016. In present study search strategy was performed by using selected keywords. Two independent investigators scanned and extracted the relevant data. The pairwise method was used to compare the difference between the mean difference weight loss for orlistat, sibutramine, lorcaserin and metformin in two direct methods (comparison of orlistat, sibutramine, lorcaserin and metformin with the control group) and non-direct (Compare orlistat, sibutramine, lorcaserin and metformin together). We assessed the quality of included trials using the quantitative 5-point Jadad scale. The heterogeneity across studies was assessed by using Cochrane’s Q and I2 tests. Publication bias was reported by means of funnel plots and Egger’s tests.  Results: The present study performed on 36 clinical studies with a population of 3672. Our study results did show that sibutramine (mean difference -4.97 kg, 95% confidence interval -6.70 to -3.23), metformin (mean difference -4.45 kg, 95% confidence interval -9.27 to 0.38), orlistat (mean difference -2.37 kg, 95% confidence interval -3.45 to -1.30), lorcaserin (mean difference -2.36 kg, 95% confidence interval -4.58 to -0.15), respectively, had the most effect on weight loss compared with the placebo group. In addition, orlistat compared to lorcaserin (mean difference -0.01 kg, 95% confidence interval -2.47 to 2.45) resulted in more weight loss, but compared to metformin (mean difference 2.07 kg, 95% confidence interval -2.78 to 7.02) and sibutramine (mean difference 0.52 kg, 95% confidence interval -4.46 to 5.50) lead to less weight loss. Conclusion: The present study indicated that orlistat had a greater effect on weight loss compared with lorcaserin, and had lower effect on weight loss compared with sibutramine and metformin in apparently healthy obese individuals.
first_indexed 2024-04-13T18:14:49Z
format Article
id doaj.art-068a41e2f1e347e7949896373a55f258
institution Directory Open Access Journal
issn 1683-1764
1735-7322
language fas
last_indexed 2024-04-13T18:14:49Z
publishDate 2018-09-01
publisher Tehran University of Medical Sciences
record_format Article
series Tehran University Medical Journal
spelling doaj.art-068a41e2f1e347e7949896373a55f2582022-12-22T02:35:43ZfasTehran University of Medical SciencesTehran University Medical Journal1683-17641735-73222018-09-01766403409A survey on clinical effectiveness of orlistat compared to sibutramine, lorcaserin, metformin and placebo on weight loss in obese people: a network meta-analysisSomaye Fatahi0Hamed Kord Varkaneh1Mehran Pezeshki2Amirhosein Ghahremanian3Sakineh Shab-Bidar4 Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran. School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran. Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran. School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran. Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran. Iran Drug and Poison Information Center, Tehran University of Medical Sciences, Tehran, Iran. Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran. Iran Drug and Poison Information Center, Tehran University of Medical Sciences, Tehran, Iran. School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran. Background: Trying to find a drug with more clinical efficacy in treating obesity is one of the priorities. The aim of this study was to evaluate the efficacy of orlistat, sibutramine, lorcaserin and metformin on weight loss in obese people. Methods: The databases of PubMed, Scopus, Google Scholar and Cochran Library were searched up to November 2016. In present study search strategy was performed by using selected keywords. Two independent investigators scanned and extracted the relevant data. The pairwise method was used to compare the difference between the mean difference weight loss for orlistat, sibutramine, lorcaserin and metformin in two direct methods (comparison of orlistat, sibutramine, lorcaserin and metformin with the control group) and non-direct (Compare orlistat, sibutramine, lorcaserin and metformin together). We assessed the quality of included trials using the quantitative 5-point Jadad scale. The heterogeneity across studies was assessed by using Cochrane’s Q and I2 tests. Publication bias was reported by means of funnel plots and Egger’s tests.  Results: The present study performed on 36 clinical studies with a population of 3672. Our study results did show that sibutramine (mean difference -4.97 kg, 95% confidence interval -6.70 to -3.23), metformin (mean difference -4.45 kg, 95% confidence interval -9.27 to 0.38), orlistat (mean difference -2.37 kg, 95% confidence interval -3.45 to -1.30), lorcaserin (mean difference -2.36 kg, 95% confidence interval -4.58 to -0.15), respectively, had the most effect on weight loss compared with the placebo group. In addition, orlistat compared to lorcaserin (mean difference -0.01 kg, 95% confidence interval -2.47 to 2.45) resulted in more weight loss, but compared to metformin (mean difference 2.07 kg, 95% confidence interval -2.78 to 7.02) and sibutramine (mean difference 0.52 kg, 95% confidence interval -4.46 to 5.50) lead to less weight loss. Conclusion: The present study indicated that orlistat had a greater effect on weight loss compared with lorcaserin, and had lower effect on weight loss compared with sibutramine and metformin in apparently healthy obese individuals.http://tumj.tums.ac.ir/browse.php?a_code=A-10-3666-83&slc_lang=en&sid=1lorcaserin metformin orlistat sibutramine weight loss
spellingShingle Somaye Fatahi
Hamed Kord Varkaneh
Mehran Pezeshki
Amirhosein Ghahremanian
Sakineh Shab-Bidar
A survey on clinical effectiveness of orlistat compared to sibutramine, lorcaserin, metformin and placebo on weight loss in obese people: a network meta-analysis
Tehran University Medical Journal
lorcaserin
metformin
orlistat
sibutramine
weight loss
title A survey on clinical effectiveness of orlistat compared to sibutramine, lorcaserin, metformin and placebo on weight loss in obese people: a network meta-analysis
title_full A survey on clinical effectiveness of orlistat compared to sibutramine, lorcaserin, metformin and placebo on weight loss in obese people: a network meta-analysis
title_fullStr A survey on clinical effectiveness of orlistat compared to sibutramine, lorcaserin, metformin and placebo on weight loss in obese people: a network meta-analysis
title_full_unstemmed A survey on clinical effectiveness of orlistat compared to sibutramine, lorcaserin, metformin and placebo on weight loss in obese people: a network meta-analysis
title_short A survey on clinical effectiveness of orlistat compared to sibutramine, lorcaserin, metformin and placebo on weight loss in obese people: a network meta-analysis
title_sort survey on clinical effectiveness of orlistat compared to sibutramine lorcaserin metformin and placebo on weight loss in obese people a network meta analysis
topic lorcaserin
metformin
orlistat
sibutramine
weight loss
url http://tumj.tums.ac.ir/browse.php?a_code=A-10-3666-83&slc_lang=en&sid=1
work_keys_str_mv AT somayefatahi asurveyonclinicaleffectivenessoforlistatcomparedtosibutraminelorcaserinmetforminandplaceboonweightlossinobesepeopleanetworkmetaanalysis
AT hamedkordvarkaneh asurveyonclinicaleffectivenessoforlistatcomparedtosibutraminelorcaserinmetforminandplaceboonweightlossinobesepeopleanetworkmetaanalysis
AT mehranpezeshki asurveyonclinicaleffectivenessoforlistatcomparedtosibutraminelorcaserinmetforminandplaceboonweightlossinobesepeopleanetworkmetaanalysis
AT amirhoseinghahremanian asurveyonclinicaleffectivenessoforlistatcomparedtosibutraminelorcaserinmetforminandplaceboonweightlossinobesepeopleanetworkmetaanalysis
AT sakinehshabbidar asurveyonclinicaleffectivenessoforlistatcomparedtosibutraminelorcaserinmetforminandplaceboonweightlossinobesepeopleanetworkmetaanalysis
AT somayefatahi surveyonclinicaleffectivenessoforlistatcomparedtosibutraminelorcaserinmetforminandplaceboonweightlossinobesepeopleanetworkmetaanalysis
AT hamedkordvarkaneh surveyonclinicaleffectivenessoforlistatcomparedtosibutraminelorcaserinmetforminandplaceboonweightlossinobesepeopleanetworkmetaanalysis
AT mehranpezeshki surveyonclinicaleffectivenessoforlistatcomparedtosibutraminelorcaserinmetforminandplaceboonweightlossinobesepeopleanetworkmetaanalysis
AT amirhoseinghahremanian surveyonclinicaleffectivenessoforlistatcomparedtosibutraminelorcaserinmetforminandplaceboonweightlossinobesepeopleanetworkmetaanalysis
AT sakinehshabbidar surveyonclinicaleffectivenessoforlistatcomparedtosibutraminelorcaserinmetforminandplaceboonweightlossinobesepeopleanetworkmetaanalysis